| Literature DB >> 32754117 |
Wen-Jing Cai1,2, Xu-Fang Liang1,2, Xiao-Chen Yuan1,2, Ai-Xuan Li1,2, Shan He1,2.
Abstract
Although studies have determined that epigenetics plays an essential role in regulating metabolism in mammals, research on nutrition-related DNA methylation remains to be lacking in teleosts. In the present study, we provided a hepatic whole-genome DNA methylation analysis in grass carp fed with moderate- or excessive-carbohydrate-level diet. Although a high-carbohydrate (HC) diet significantly changed the mRNA expression levels of metabolic genes, it did not affect the global genomic DNA methylation levels in grass carp liver. However, compared with the control group, 3,972 genes were hyper-methylated and 2,904 genes were hypo-methylated in the promoter region. Meanwhile, 10,711 genes were hyper-methylated and 6,764 genes were hypo-methylated in the gene body region in the HC group. These differentially methylated genes (DMGs) were enriched in multiple pathways, including carbohydrate metabolism, insulin pathway, lipid metabolism, and adipocytokine signaling pathway. In addition, the variations in DNA methylation significantly regulated the transcription levels of key genes of metabolism, which could affect the glucose concentrations and the lipid deposition of grass carp. Furthermore, we compared the DNA methylation alterations of genes in glucose metabolism and obesity pathways of grass carp with those of mammalian models in different nutritional states. The results showed that most of the DMGs in grass carp were also regulated by DNA methylation in mammals when the nutritional state changed. The findings revealed more differentially methylated regions and candidate genes for glucose metabolism and broken species boundaries.Entities:
Keywords: grass carp; high carbohydrate intake; hyperglycemia; metabolism; whole-genome DNA methylation analysis
Mesh:
Substances:
Year: 2020 PMID: 32754117 PMCID: PMC7381294 DOI: 10.3389/fendo.2020.00398
Source DB: PubMed Journal: Front Endocrinol (Lausanne) ISSN: 1664-2392 Impact factor: 5.555
Composition of the experimental diets.
| Casein | 32 | 32 |
| Gelatin | 8 | 8 |
| Fish oil | 3 | 3 |
| Soybean oil | 3 | 3 |
| Corn starch | 25 | 42 |
| Cellulose | 22.8 | 5.8 |
| Vitamin mixture | 1 | 1 |
| Mineral mixture | 1 | 1 |
| Ca(H2PO4)2 | 1.65 | 1.65 |
| Carboxymethyl cellulose | 2 | 2 |
| Choline chloride (50%) | 0.5 | 0.5 |
| Ethoxyquin (30%) | 0.05 | 0.05 |
| Crude protein | 36.96 | 37.14 |
| Crude lipid | 6.35 | 6.24 |
| Carbohydrate | 25.21 | 45.30 |
| Ash | 2.50 | 2.84 |
| Cross energy (kJ g−1) | 11.87 | 15.12 |
Vitamin premix (per kilogram of diet): vitamin A, 2,000 IU; vitamin B1 (thiamin), 5 mg; vitamin B2 (riboflavin), 5 mg; vitamin B6, 5 mg; vitamin B12, 0.025 mg; vitamin D3, 1,200 IU; vitamin E, 21 mg; vitamin K3, 2.5 mg; folic acid, 1.3 mg; biotin, 0.05 mg; pantothenic acid calcium, 20 mg; inositol, 60 mg; ascorbic acid (35%), 110 mg; and niacinamide, 25 mg.
Mineral premixes (per kilogram of diet): MnSO.
Primer sequences for the quantitative real-time PCR.
| pepck | pepck-F | ATCGTCACGGAGAACCAA | |
| pepck-R | CCTGAACACCAAACTTAGCA | ||
| gs | gs-F | CCTCCAGTAACAACTCACAACA | |
| gs-R | CAGATAGATTGGTGGTTACGC | ||
| pk | pk-F | GCCGAGAAAGTCTTCATCGCACAG | |
| pk-R | CGTCCAGAACCGCATTAGCCAC | ||
| g6pca.1 | g6pca.1-F | CTACAACGCAAGTCTGAGAAAGT | |
| g6pca.1-R | CAGTCTGGATTGACGCACC | ||
| acc1 | acc1-F | TGGCTGCACTGCACTCTCACT | |
| acc1-R | GGTCCAGCTTCCCTGCGGTC | ||
| fasn | fasn-F | GATGGGTCTACAGCCTGATGG | |
| fasn-R | GACACCCTGTGGACATTGAGC | ||
| cpt1 | cpt1-F | GCCACTGTAAAGGAGAACC | |
| cpt1-R | GGATGCCTCATAAGTCAAG | ||
| atgl | atgl-F | TCGTGCAAGCGTGTATATG | |
| atgl-R | GCTCGTACTGAGGCAAATTA | ||
| pparα | pparα-F | AGCAGAGAAGGACGTCAG | |
| pparα-R | TTCCTTCTCGGCATGCTG | ||
| srebp1 | srebp1-F | CTTCCTCTTGTTCGCCTGCT | |
| srebp1-R | CCTTTTGCCATACCTCTGCC | ||
| pgc α | pgc1α-F | CAGGAAACTACTAAGGGACCAG | |
| pgc1α-R | TGAGATGAGGAACGGGAGC | ||
| insrb | insrb-F | GTCCACCACCAACCCTGAA | |
| insrb-R | TCCCGCCCTTGCGATAAT | ||
| foxo1 | foxo1-F | GCTTGAACTGGTGTCGGTCTC | |
| foxo1-R | GCCGCTCGTCCTCTGCTC | ||
| socs3 | socs3-F | GCTGCCGTCTCACCGTTAC | |
| socs3-R | ATGCTCTTGGAGTCCGTTTGT | ||
| ampkα | ampkα-F | GTCCAAGCATCTCGGTGTTC | |
| ampkα-R | GGGTTCTTCCTCCGCACT | ||
| leptin a | leptin a-F | TGAGCATTCTTGGTATGATTGA | |
| leptin a-R | ATTCTGTGGATGATGGTGTCTG | ||
| ef1α | ef1α-F | GCTGACTGTGCCGTGCTGAT | |
| ef1α-R | GCTGACTTCCTTGGTGATTTCC |
Figure 1Growth performance and serum components in grass carp fed with moderate carbohydrate diet (control) or excessive carbohydrate diet. (A) Weight gain. (B) Specific growth ratio. (C) Food intake. (D) Body crude lipid contents. (E) Concentration of serum glucose. (F) Concentration of serum insulin. Values are mean ± SEM (n = 6). The vertical bars which are not sharing the same letter are significantly different (P < 0.05).
Figure 2Scatterplot of the enriched top 20 Kyoto Encyclopedia of Genes and Genome pathways of differentially methylated genes (DMGs) that differentially methylated in the promoter (A) and the gene body regions (B). The y-axis represents the enriched pathways, and the x-axis represents the rich factor of the corresponding pathways; the size of the spots represents the number of genes related to differentially methylated regions enriched in each pathway, while the color of the spot represents the corrected p-value of each pathway. The rich factors indicate the ratio of the number of DMGs mapped to a certain pathway to the total number of genes mapped to this pathway. Greater rich factor means greater enrichment.
Figure 3Differentially methylated genes enriched in the carbohydrate metabolism. (A) Genes differentially methylated in the promoter region. (B) Genes differentially methylated in the gene body regions. The colors of the ellipses were shaded according to significance level. Red: the DNA methylation levels of the control group were significantly higher than those in the high carbohydrate (HC) group [log2ratio(control/HC) ≥ 0 and corrected p ≤ 0.05]. Green: the DNA methylation levels of the control group were significantly lower than those in the HC group (log2ratio(control/HC) ≥ 0 and corrected p ≤ 0.05). Gray: not significantly changed.
Figure 4Differentially methylated genes enriched in the lipid metabolism. (A) Genes differentially methylated in the promoter region. (B) Genes differentially methylated in the gene body regions. The colors of the ellipses were shaded according to significance level. Red: the DNA methylation levels of the control group were significantly higher than those in the high carbohydrate (HC) group [log2ratio(control/HC) ≥ 0 and corrected p ≤ 0.05]. Green: the DNA methylation levels of the control group were significantly lower than those in the HC group [log2ratio(control/HC) ≥ 0 and corrected p ≤ 0.05]. Gray: not significantly changed.
Figure 5Differentially methylated genes enriched in the insulin signaling pathway. (A) Genes differentially methylated in the promoter region. (B) Genes differentially methylated in the gene body regions. The colors of the ellipses were shaded according to significance level. Red: the DNA methylation levels of the control group were significantly higher than those in the high carbohydrate (HC) group [log2ratio(control/HC) ≥ 0 and corrected p ≤ 0.05]. Green: the DNA methylation levels of the control group were significantly lower than those in the HC group [log2ratio(control/HC) ≥ 0 and corrected p ≤ 0.05]. Gray: not significantly changed.
Figure 6Differentially methylated genes enriched in the adipocytokine signaling pathway. (A) Genes differentially methylated in the promoter region. (B) Genes differentially methylated in the gene body regions. The colors of the ellipses were shaded according to significance level. Red: the DNA methylation levels of the control group were significantly higher than those in the high carbohydrate (HC) group [log2ratio(control/HC) ≥ 0 and corrected p ≤ 0.05]. Green: the DNA methylation levels of the control group were significantly lower than those in the HC group [log2ratio(control/HC) ≥ 0 and corrected p ≤ 0.05]. Gray: not significantly changed.
Figure 7Differentially methylated genes enriched in the AMPK signaling pathway. (A) Genes differentially methylated in the promoter region. (B) Genes differentially methylated in the gene body regions. The colors of the ellipses were shaded according to significance level. Red: the DNA methylation levels of the control group were significantly higher than those in the high carbohydrate (HC) group [log2ratio(control/HC) ≥ 0 and corrected p ≤ 0.05]. Green: the DNA methylation levels of the control group were significantly lower than those in the HC group (log2ratio(control/HC) ≥ 0 and corrected p ≤ 0.05). Gray: not significantly changed.
Figure 8Hepatic mRNA expression levels of different methylated genes (DMGs) in grass carp fed with different carbohydrate levels. (A) mRNA expression levels of DMGs involved in carbohydrate metabolism. (B) mRNA expression levels of DMGs involved in lipid metabolism. (C) mRNA expression levels of different methylated transcription factor genes related to metabolism. (D) mRNA expression levels of DMGs in insulin pathway, adipocytokine pathway and AMPK pathway. (E) A summarization of the mRNA expression levels and DNA methylation pattern of the DMGs. Values are mean ± S.E.M. (n = 6). Vertical bars not sharing the same letter are significantly different (p < 0.05).
Figure 9The glucose concentration difference of L8824 cell culture medium treated with different concentrations of glucose and 5-Aza-2′-deoxycytidine for 48 h. Values are mean ± SEM (n = 3). The vertical bars not sharing the same letter are significantly different (p < 0.05).
Comparison of DNA methylation alterations of metabolism-related genes with mammal models of obesity and type 2 diabetes.
| FABP | Liver type fatty acid binding protein | √ | √ | Human adipose | Polyunsaturated and saturated fat overfeeding induce distinct epigenetic changes, including fatty acid binding protein | ( |
| LPL | Lipoprotein lipase | √ | / | Rat adipose | Maternal prenatal folic acid supplementation programs offspring lipid metabolism by aberrant DNA methylation in LPL gene | ( |
| ATGL | Adipose triglyceride lipase | √ | / | Rat liver | Maternal prenatal folic acid supplementation programs offspring lipid metabolism by aberrant DNA methylation in ATGL gene | ( |
| FASN | Fatty acid synthase | √ | √ | Rat liver | High-fat diet induced lipid-synthesizing genes via gene body methylation of FAS and ACC1 | ( |
| ACC1 | Acetyl-CoA carboxylase 1 | / | √ | Rat liver | High-fat diet induced lipid-synthesizing genes via gene body methylation of FAS and ACC1 | ( |
| CPT1 | Carnitine palmitoyltransferase 1Ab | √ | √ | Rat liver | High fructose consumption induced DNA methylation in PPARα and CPT1A promoter | ( |
| FATB | Solute carrier family 27, member 1/4 | / | √ | – | – | – |
| HSL | Hormone sensitive lipase | / | √ | Adipose tissue of metabolic syndrome patients | DNA methylation of LPL was associated with triglyceride concentrations in the metabolic syndrome | ( |
| CS | Citrate synthase | √ | √ | – | – | – |
| GS | Glycogen synthase | √ | / | – | – | – |
| GK | Glucokinase | √ | / | Rat liver | Obese rats fed with high-fat diet revealed hypermethylation in promoter regions of hepatic gk and pk | ( |
| PK | Pyruvate kinase | √ | √ | Rat liver | Obese rats fed with high-fat diet revealed hypermethylation in promoter regions of hepatic gk and pk | ( |
| G6PC | Glucose 6-phosphatase alpha | √ | / | Piglet liver | Betaine supplementation in maternal diet reduced the DNA methylation in G6PC and improved the G6PC mRNA expression | ( |
| PEPCK1 | Phosphoenolpyruvate carboxykinase 1 | √ | / | Piglet liver | Betaine supplementation in maternal diet improved the DNA methylation of PEPCK1 promoter and diminished the PEPCK1 mRNA expression | ( |
| PEPCK2 | Phosphoenolpyruvate carboxykinase 2 | √ | √ | – | – | – |
| PFK1 | 6-Phosphofructokinase 1 | / | √ | – | – | – |
| PFK2 | 6-Phosphofructokinase 2 | √ | √ | – | – | – |
| FBP1 | Fructose-1,6-bisphosphatase 1 | / | √ | Human hepatocellular carcinoma and colon cancer | Hypermethylation of FBP1 promoter down-regulated FBP1 expression | ( |
| INS | Insulin | √ | / | Mouse embryonic stem cell | Ins2 was fully methylated and became demethylated as the cells differentiate into insulin-expressing cells | ( |
| IRA | Insulin receptor A | / | √ | Hypothalamus of rat | Insulin receptor promoter is vulnerable to hypermethylation due to overnutrition, probably especially glucose dependent in a dose–response manner | ( |
| IRB | Insulin receptor B | / | √ | – | – | – |
| IRS | Insulin receptor substrate | / | √ | Human blood | There was no association between IRS-1 promoter methylation and type 2 diabetes between genders | ( |
| SREBP1 | Sterol regulatory element binding transcription factor 1 | / | √ | Human adipose | The promoter of SREBF1 was hypomethylated under vitamin B12-deficient conditions | ( |
| IL-6 | Interleukin 6 | / | √ | Peripheral blood mononuclear cells | The methylation status of a single CpG site in the IL6 promoter is related to IL6 mRNA expression and rheumatoid arthritis | ( |
| TNFα | Tumor necrosis factor α | / | √ | Human adipose | TNF α promoter methylation levels could be used as epigenetic biomarkers concerning response to low-calorie diet | ( |
| LepR | Leptin receptor | / | √ | – | – | – |
| AdipoR | Adiponectin receptor | √ | / | – | – | – |
| SOCS3 | Suppressor of cytokine signaling 3 | √ | / | Peripheral blood mononuclear cells | DNA methylation of SOCS3 was inversely related with metabolic syndrome | ( |
| PPARα | Peroxisome proliferator-activated receptors α a | √ | √ | Rat liver | High fructose consumption induces DNA methylation at PPARα and CPT1A promoter | ( |
| AMPK | 5′-AMP-activated protein kinase | √ | √ | Human blood and mouse muscle | DNA methylation of AMPK gene increased after moderate-endurance exercise in humans and mice | ( |
| PGC-1α | Peroxisome proliferator-activated receptor gamma coactivator 1 α | √ | √ | Human THP-1 monocytes and rat adipose | Supplementation with saturated fatty acids and elaidic acid induced the hypermethylation of PPARG1 | ( |